Epietiocholanolone

From WikiMD's WELLNESSPEDIA


Chemical structure of Epietiocholanolone

Epietiocholanolone is a steroid metabolite that is derived from the androgen testosterone. It is one of the many metabolites that are produced during the breakdown of testosterone in the body. Epietiocholanolone is classified as an etiocholanolone, which is a type of ketosteroid.

Biochemistry[edit]

Epietiocholanolone is formed through the metabolism of testosterone via the enzyme 5_-reductase. This enzyme converts testosterone into dihydrotestosterone (DHT), which is then further metabolized into various compounds, including epietiocholanolone. The process involves the reduction of the 4,5-double bond in testosterone, followed by hydroxylation and oxidation reactions.

Function[edit]

While epietiocholanolone itself does not have significant androgenic activity, it is an important marker in the study of steroid metabolism and can be used in clinical settings to assess adrenal gland function and androgen production. It is often measured in urine as part of a steroid profile.

Clinical Significance[edit]

Epietiocholanolone levels can be indicative of certain medical conditions. Elevated levels may be associated with adrenal hyperplasia or androgen-secreting tumors. Conversely, low levels might be seen in conditions such as hypogonadism.

Related Compounds[edit]

Epietiocholanolone is closely related to other steroid metabolites such as androsterone and etiocholanolone. These compounds are also products of testosterone metabolism and share similar pathways in their formation.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.